Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Oct;12(10):78-82.
doi: 10.13107/jocr.2022.v12.i10.3376.

Case Report - Short-term Bisphosphonate Use Associated Stress Fractures

Affiliations
Case Reports

Case Report - Short-term Bisphosphonate Use Associated Stress Fractures

Arshan J Dadrewalla et al. J Orthop Case Rep. 2022 Oct.

Abstract

Introduction: Long-term bisphosphonate use has been linked to an increased risk of pathological neck of femur fractures.

Case report: We write concerning a patient who presented with the left hip pain following a low impact fall, which was diagnosed as a pathological left neck of femur fracture. This was a subtrochanteric stress fracture most frequently seen in patients who take bisphosphonate medications. A key point of difference in our patient is the length of time of bisphosphonate use. A further interesting point was the method of imaging used to diagnose this fracture whereby plain radiographs and computerized tomography imaging both did not show any acute fracture whereas only a magnetic resonance imaging (MRI) hip demonstrated this fracture. Surgical insertion of a prophylactic intramedullary nail was done to stabilize the fracture and reduce the risk of progression to a complete fracture.

Conclusion: This case brings up multiple key points not reviewed previously such as the fact a fracture developed only 1 month after bisphosphonate use rather than months or years. These points suggest that there should be a low threshold for investigation (including MRI scanning) into potential pathological fractures and that bisphosphonate use should be a red flag to initiate these investigations regardless of length of use.

Keywords: Atypical stress fractures; bisphosphonate use; magnetic resonance imaging.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil

Figures

Figure 1
Figure 1
Blood tests result on admission.
Figure 2
Figure 2
Plain radiographs of pelvis and left femur.
Figure 3
Figure 3
Coronal images of CT hip.
Figure 4
Figure 4
Coronal image of MRI hip showing left lateral femur fracture.
Figure 5
Figure 5
X-ray image of left femur following insertion of IM nail.

References

    1. Ward WG, Sr, Carter CJ, Wilson SC, Emory CL. Femoral stress fractures associated with long-term bisphosphonate treatment. Clin Orthop Relat Res. 2012;470:759–65. - PMC - PubMed
    1. Meier RP, Perneger TV, Stern R, Rizzoli R, Peter RE. Increasing occurrence of atypical femoral fractures associated with bisphosphonate use. Arch Intern Med. 2012;172:930–6. - PubMed
    1. Ward W, Carter CJ. Bisphosphonate-associated subtrochanteric stress fractures:An emerging epidemic. Orthop Proc. 2018:94.
    1. Pozzi S, Raje N. The role of bisphosphonates in multiple myeloma:Mechanisms, side effects, and the future. Oncologist. 2011;16:651–62. - PMC - PubMed
    1. Mhaskar R, Kumar A, Miladinovic B, Djulbegovic B. Bisphosphonates in multiple myeloma:An updated network meta-analysis. Cochrane Database Syst Rev. 2017;12:CD003188. - PMC - PubMed

Publication types

LinkOut - more resources